125 related articles for article (PubMed ID: 22836584)
41. Synthesis of (S)-(+)-decursin and its analogues as potent inhibitors of melanin formation in B16 murine melanoma cells.
Lee K; Lee JH; Boovanahalli SK; Choi Y; Choo SJ; Yoo ID; Kim DH; Yun MY; Lee GW; Song GY
Eur J Med Chem; 2010 Dec; 45(12):5567-75. PubMed ID: 20884093
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and evaluation of the alpha-glucosidase inhibitory activity of 3-[4-(phenylsulfonamido)benzoyl]-2H-1-benzopyran-2-one derivatives.
Wang S; Yan J; Wang X; Yang Z; Lin F; Zhang T
Eur J Med Chem; 2010 Mar; 45(3):1250-5. PubMed ID: 20045223
[TBL] [Abstract][Full Text] [Related]
43. Spectroscopic and electrochemical characterization of gold(I) and gold(III) complexes with glyoxaldehyde bis(thiosemicarbazones): cytotoxicity against human tumor cell lines and inhibition of thioredoxin reductase activity.
Lessa JA; Ferraz KS; Guerra JC; de Miranda LF; Romeiro CF; Souza-Fagundes EM; Barbeira PJ; Beraldo H
Biometals; 2012 Jun; 25(3):587-98. PubMed ID: 22526562
[TBL] [Abstract][Full Text] [Related]
44. Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.
Serebryanskaya TV; Lyakhov AS; Ivashkevich LS; Schur J; Frias C; Prokop A; Ott I
Dalton Trans; 2015 Jan; 44(3):1161-9. PubMed ID: 25413270
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes.
Mahmoodi M; Aliabadi A; Emami S; Safavi M; Rajabalian S; Mohagheghi MA; Khoshzaban A; Samzadeh-Kermani A; Lamei N; Shafiee A; Foroumadi A
Arch Pharm (Weinheim); 2010 Jul; 343(7):411-6. PubMed ID: 20309872
[TBL] [Abstract][Full Text] [Related]
46. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Crogan-Grundy C; Labreque D; Bubenick M; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2008 Feb; 51(3):417-23. PubMed ID: 18197614
[TBL] [Abstract][Full Text] [Related]
47. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
48. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES
Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964
[TBL] [Abstract][Full Text] [Related]
51. In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury.
Wagner C; Sudati JH; Nogueira CW; Rocha JB
Biometals; 2010 Dec; 23(6):1171-7. PubMed ID: 20717703
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.
Millet R; Urig S; Jacob J; Amtmann E; Moulinoux JP; Gromer S; Becker K; Davioud-Charvet E
J Med Chem; 2005 Nov; 48(22):7024-39. PubMed ID: 16250662
[TBL] [Abstract][Full Text] [Related]
53. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions.
Kemnitzer W; Kasibhatla S; Jiang S; Zhang H; Zhao J; Jia S; Xu L; Crogan-Grundy C; Denis R; Barriault N; Vaillancourt L; Charron S; Dodd J; Attardo G; Labrecque D; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2005 Nov; 15(21):4745-51. PubMed ID: 16143530
[TBL] [Abstract][Full Text] [Related]
54. Diterpenoids with thioredoxin reductase inhibitory activities from Jatropha multifida.
Zhu JY; Zhang CY; Dai JJ; Rahman K; Zhang H
Nat Prod Res; 2017 Dec; 31(23):2753-2758. PubMed ID: 28281377
[TBL] [Abstract][Full Text] [Related]
55. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
Cassidy PB; Edes K; Nelson CC; Parsawar K; Fitzpatrick FA; Moos PJ
Carcinogenesis; 2006 Dec; 27(12):2538-49. PubMed ID: 16777982
[TBL] [Abstract][Full Text] [Related]
56. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells.
Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH
J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608
[TBL] [Abstract][Full Text] [Related]
57. On the potential of thioredoxin reductase inhibitors for cancer therapy.
Urig S; Becker K
Semin Cancer Biol; 2006 Dec; 16(6):452-65. PubMed ID: 17056271
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and structure-activity relationship studies of novel millepachine derivatives as potent antiproliferative agents.
Wang G; Wu W; Peng F; Cao D; Yang Z; Ma L; Qiu N; Ye H; Han X; Chen J; Qiu J; Sang Y; Liang X; Ran Y; Peng A; Wei Y; Chen L
Eur J Med Chem; 2012 Aug; 54():793-803. PubMed ID: 22784822
[TBL] [Abstract][Full Text] [Related]
60. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells.
Engman L; Kandra T; Gallegos A; Williams R; Powis G
Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]